ThreatDown, the corporate business unit of Malwarebytes, today published research documenting what researchers believe to be the first documented case of attackers abusing the Deno JavaScript runtime ...

Every developer should be paying attention to the local-first architecture movement and what it means for JavaScript. Here’s ...

The Wikimedia Foundation suffered a security incident today after a self-propagating JavaScript worm began vandalizing pages and modifying user scripts across multiple wikis.

Unicorn adds modern reactive component functionality to your Django templates without having to learn a new templating language or fight with complicated JavaScript frameworks. It seamlessly extends ...

From what I see, ET is actively targeting AI-driven energy demand that should help them move from an acquisition-heavy model to a high-yield organic growth phase in the next few years, thus protecting ...

Town Hall Theater will present Christine Tassan et les Imposteures on Sunday, February 8, from 4:00 to 5:45 p.m. on the Rothrock Mainstage at Town Hall Theater, located at 76 Merchants Row in ...

Energy Transfer LP (NYSE:ET) ranks among the best stocks under $25 to buy now. On December 15, RBC Capital reaffirmed coverage of Energy Transfer LP (NYSE:ET) with an Outperform rating and a $22 price ...

I'm a software developer and writer, passionate about learning and sharing knowledge and one way I do that is through writing. Que sont les tableaux en JavaScript ? Les tableaux JavaScript sont des ...

Fury Tires introduced the Track Hunter ET, a DOT-compliant competition tire engineered for dry-pavement performance in high-horsepower builds. The tire uses a sticky compound and a tuned tread profile ...

Netflix hit “Stranger Things” is a melting pot of ‘80s pop culture. Ever since the retro series premiered in 2016 – following the small town ‘80s supernatural adventures of Eleven (Millie Bobby Brown) ...

Patients with essential thrombocythemia (ET) have limited treatment options; anagrelide is the only FDA-approved drug and is often deemed inadequate. A monoclonal antibody targeting CALR mutations ...